Frequency and clinical significance of BCR-ABL mutations in patients with chronic myeloid leukemia treated with imatinib mesylate

E. Jabbour, H. Kantarjian, D. Jones, M. Talpaz, N. Bekele, S. O'Brien, X. Zhou, R. Luthra, G. Garcia-Manero, F. Giles, M. B. Rios, S. Verstovsek, J. Cortes

Research output: Contribution to journal › Article › peer-review